Improved Medically Assisted Procreation Monitoring

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-15

Study Completion Date

2018-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patient care in Medically Assisted Procreation (MAP) requires a close and regular monitoring of the evolution of the estradiol rate. This monitoring allows the dose and duration of treatment to be accurately adjusted for each woman (every 24 or 48 hours) up to 10 to 15 days of treatment with gonadotrophins. Oestradiol (E2) is secreted by the growing ovarian follicles and reflects their growth and maturity. Its plasma dosage makes it possible to monitor the ovarian response to stimulation.

This monitoring involves several constraints amongst which disruption of work life, stress, fatigue that can alter the response to treatment

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Two Methods for Progesterone Dosage During IVF

NCT05987657

Infertility

COMPLETED NA

Evaluation of Salivary ELISA for Hormone Monitoring in IVF Patients

NCT05184777

Infertility, Female Reproductive Sterility

COMPLETED NA

Evaluation of Salivary ELISA for Hormone Monitoring in Donors

NCT05780489

Infertility, Female Reproductive Sterility

RECRUITING NA

AMH and Dosing Regimens for Initial IVF Stimulation Protocols

NCT03098199

Infertility

COMPLETED NA

Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality

NCT03139474

Infertility, Female

UNKNOWN PHASE2/PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In order to improve the comfort of patients already under severe stress, simplification of this monitoring is proposed. The development of an immediate-release whole blood test for simplified monitoring of estradiol levels will provide considerable comfort in the management of patients. These patients are subjected to significant emotional and physical stress and the development of this test will reduce the negative consequences that result.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women with ovarian stimulation

Women followed in the MAP center of the Rennes University Hospital for ovarian stimulation monitoring Dosage of oestradiol

Dosage of oestradiol

Intervention Type DIAGNOSTIC_TEST

The study is based on a concept using capillary blood tests using lateral flow by migration on membrane similarly to a pregnancy test, patented by a french company (NGBiotech).

This study is therefore a feasibility study of a rapid test for oestradiol dosage during monitoring of ovarian stimulation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dosage of oestradiol

The study is based on a concept using capillary blood tests using lateral flow by migration on membrane similarly to a pregnancy test, patented by a french company (NGBiotech).

This study is therefore a feasibility study of a rapid test for oestradiol dosage during monitoring of ovarian stimulation.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women over 18 years old
* Patient followed for monitoring of ovarian stimulation;
* Having received information on the protocol and given consent to participate